Oncocyte To Announce Second Quarter 2023 Financial Results

Rhea-AI Summary

Oncocyte Corporation (NASDAQ:OCX) will release its second quarter 2023 financial results on August 10, 2023. The company will host a conference call and webcast to discuss its financial results and recent highlights. Interested parties can access the live call via telephone or the company's website.

Conference Call and Webcast on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET

IRVINE, CA / ACCESSWIRE / August 3, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that it will release its second quarter 2023 financial results on Thursday, August 10, 2023, prior to the U.S. market open. The company will host a conference call and webcast on Thursday, August 10, 2023, at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (877) 317-6789 for domestic callers and (412) 317-6789 for international callers. Once dialed in ask to be joined to the Oncocyte Corporation call.

The live webinar of the call may be accessed by visiting the "Events & Presentation" section of the Company's website at https://investors.oncocyte.com. A replay of the webinar will be available on the Company's website shortly after the conclusion of the call. 

About Oncocyte
Oncocyte is a precision diagnostics company. The Company's tests are designed to help provide clarity and confidence to physicians and their patients. VitaGraft™ is a blood-based solid organ transplantation monitoring test, DetermaIO™ is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies, and the pipeline test DetermaCNI™ is blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. For more information, visit https://oncocyte.com/

VitaGraft™, DetermaIO™, and DetermaCNI™ are trademarks of Oncocyte Corporation.

CONTACT:
Stephanie Prince
PCG Advisory
(646) 863-6341
sprince@pcgadvisory.com

SOURCE: Oncocyte
via PRISM Mediawire, LLC

View source version on accesswire.com:
https://www.accesswire.com/771952/Oncocyte-To-Announce-Second-Quarter-2023-Financial-Results

FAQ

When will Oncocyte Corporation release its second quarter 2023 financial results?

Oncocyte Corporation will release its second quarter 2023 financial results on August 10, 2023.

What is the ticker symbol for Oncocyte Corporation?

The ticker symbol for Oncocyte Corporation is OCX.

How can I access the live conference call?

You can access the live conference call by dialing (877) 317-6789 for domestic callers and (412) 317-6789 for international callers. Alternatively, you can access the live webinar on the company's website.

Where can I find a replay of the webinar?

A replay of the webinar will be available on the Company's website shortly after the conclusion of the call.